Gene Symbol | Gene ID | Gene Info |
---|---|---|
E2F3
|
ENSG00000112242.10 | E2F transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_20403060_20403211 | E2F3 | 737 | 0.620199 | 0.91 | 7.0e-04 | Click! |
chr6_20403272_20403538 | E2F3 | 629 | 0.681419 | 0.87 | 2.0e-03 | Click! |
chr6_20402900_20403051 | E2F3 | 577 | 0.713829 | 0.87 | 2.5e-03 | Click! |
chr6_20411698_20411910 | E2F3 | 7770 | 0.150351 | 0.85 | 3.8e-03 | Click! |
chr6_20401259_20401487 | E2F3 | 1025 | 0.490743 | 0.83 | 5.8e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_24882118_24882271 | 2.57 |
NCMAP |
noncompact myelin associated protein |
408 |
0.83 |
chr8_145750201_145750352 | 2.39 |
LRRC24 |
leucine rich repeat containing 24 |
2126 |
0.11 |
chr10_105212010_105212161 | 2.35 |
CALHM2 |
calcium homeostasis modulator 2 |
10 |
0.88 |
chr17_48277363_48277626 | 2.35 |
COL1A1 |
collagen, type I, alpha 1 |
58 |
0.96 |
chr10_119303450_119303630 | 2.32 |
EMX2 |
empty spiracles homeobox 2 |
1031 |
0.41 |
chr7_143599335_143599486 | 2.09 |
FAM115A |
family with sequence similarity 115, member A |
119 |
0.96 |
chr13_103452424_103452575 | 2.09 |
BIVM |
basic, immunoglobulin-like variable motif containing |
938 |
0.34 |
chr10_103990547_103990698 | 2.09 |
PITX3 |
paired-like homeodomain 3 |
1218 |
0.37 |
chr15_66995452_66995652 | 2.05 |
SMAD6 |
SMAD family member 6 |
878 |
0.68 |
chr22_39268574_39268744 | 1.97 |
CBX6 |
chromobox homolog 6 |
340 |
0.85 |
chr5_132165870_132166087 | 1.96 |
SHROOM1 |
shroom family member 1 |
373 |
0.78 |
chr7_5467552_5467749 | 1.93 |
TNRC18 |
trinucleotide repeat containing 18 |
2605 |
0.2 |
chr11_61658641_61658792 | 1.93 |
FADS3 |
fatty acid desaturase 3 |
137 |
0.94 |
chr5_77591328_77591479 | 1.92 |
AP3B1 |
adaptor-related protein complex 3, beta 1 subunit |
824 |
0.63 |
chr4_55099358_55099536 | 1.91 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
2958 |
0.36 |
chr13_25946761_25946912 | 1.90 |
ATP8A2 |
ATPase, aminophospholipid transporter, class I, type 8A, member 2 |
627 |
0.77 |
chr22_39541315_39541466 | 1.88 |
CBX7 |
chromobox homolog 7 |
7059 |
0.17 |
chr5_132947014_132947165 | 1.85 |
FSTL4 |
follistatin-like 4 |
1166 |
0.56 |
chr4_13545944_13546095 | 1.84 |
NKX3-2 |
NK3 homeobox 2 |
655 |
0.76 |
chr15_33011128_33011364 | 1.84 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
1041 |
0.55 |
chr22_30642550_30642701 | 1.77 |
LIF |
leukemia inhibitory factor |
103 |
0.82 |
chr20_826315_826525 | 1.76 |
FAM110A |
family with sequence similarity 110, member A |
653 |
0.77 |
chr3_150128773_150128924 | 1.76 |
TSC22D2 |
TSC22 domain family, member 2 |
52 |
0.99 |
chr10_111970132_111970295 | 1.75 |
MXI1 |
MAX interactor 1, dimerization protein |
224 |
0.93 |
chr1_240775440_240775591 | 1.74 |
GREM2 |
gremlin 2, DAN family BMP antagonist |
66 |
0.98 |
chr1_6662289_6662440 | 1.74 |
KLHL21 |
kelch-like family member 21 |
565 |
0.64 |
chr17_79860161_79860345 | 1.73 |
NPB |
neuropeptide B |
268 |
0.73 |
chr14_101151044_101151274 | 1.71 |
DLK1 |
delta-like 1 homolog (Drosophila) |
40883 |
0.08 |
chr1_26372816_26373036 | 1.70 |
SLC30A2 |
solute carrier family 30 (zinc transporter), member 2 |
302 |
0.82 |
chr10_73723963_73724261 | 1.69 |
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
11 |
0.99 |
chr20_18039793_18039944 | 1.66 |
RP4-726N1.2 |
|
269 |
0.85 |
chr21_45564672_45564905 | 1.64 |
C21orf33 |
chromosome 21 open reading frame 33 |
8787 |
0.15 |
chr10_88854250_88854401 | 1.63 |
GLUD1 |
glutamate dehydrogenase 1 |
298 |
0.57 |
chr7_155264148_155264299 | 1.62 |
EN2 |
engrailed homeobox 2 |
13399 |
0.19 |
chr1_21671441_21671592 | 1.62 |
ECE1 |
endothelin converting enzyme 1 |
481 |
0.84 |
chr22_46440489_46440640 | 1.60 |
RP6-109B7.5 |
|
8409 |
0.11 |
chr12_42876919_42877147 | 1.58 |
PRICKLE1 |
prickle homolog 1 (Drosophila) |
159 |
0.95 |
chr19_39522528_39522778 | 1.58 |
FBXO27 |
F-box protein 27 |
512 |
0.63 |
chr7_32981714_32982094 | 1.57 |
RP9P |
retinitis pigmentosa 9 pseudogene |
671 |
0.69 |
chr4_1729692_1729850 | 1.57 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
360 |
0.83 |
chr1_107682967_107683366 | 1.55 |
NTNG1 |
netrin G1 |
276 |
0.95 |
chr9_128002968_128003119 | 1.54 |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
566 |
0.56 |
chr9_38068361_38068574 | 1.54 |
SHB |
Src homology 2 domain containing adaptor protein B |
741 |
0.75 |
chr2_122405151_122406002 | 1.54 |
CLASP1 |
cytoplasmic linker associated protein 1 |
1476 |
0.32 |
chr15_62683020_62683244 | 1.54 |
RP11-299H22.5 |
|
120253 |
0.05 |
chr5_32712034_32712340 | 1.53 |
NPR3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
250 |
0.95 |
chr18_46501891_46502080 | 1.53 |
SMAD7 |
SMAD family member 7 |
24904 |
0.19 |
chr9_130831349_130831676 | 1.52 |
SLC25A25 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
940 |
0.35 |
chr3_129325066_129325247 | 1.52 |
PLXND1 |
plexin D1 |
505 |
0.77 |
chr1_244012772_244012927 | 1.52 |
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
581 |
0.82 |
chr9_4298563_4298844 | 1.51 |
GLIS3 |
GLIS family zinc finger 3 |
207 |
0.84 |
chr9_139538532_139538731 | 1.51 |
EGFL7 |
EGF-like-domain, multiple 7 |
14677 |
0.09 |
chr7_44646767_44646918 | 1.50 |
OGDH |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
604 |
0.72 |
chr16_88729091_88729284 | 1.50 |
MVD |
mevalonate (diphospho) decarboxylase |
331 |
0.56 |
chr12_71833574_71833725 | 1.49 |
LGR5 |
leucine-rich repeat containing G protein-coupled receptor 5 |
99 |
0.97 |
chr9_140173644_140173795 | 1.48 |
TOR4A |
torsin family 4, member A |
1518 |
0.19 |
chr7_155259269_155259467 | 1.48 |
EN2 |
engrailed homeobox 2 |
8544 |
0.2 |
chr16_87660880_87661031 | 1.48 |
JPH3 |
junctophilin 3 |
24444 |
0.16 |
chr21_38078754_38078908 | 1.47 |
SIM2 |
single-minded family bHLH transcription factor 2 |
2650 |
0.28 |
chr12_81330977_81331128 | 1.47 |
LIN7A |
lin-7 homolog A (C. elegans) |
431 |
0.52 |
chr4_108911771_108911922 | 1.46 |
HADH |
hydroxyacyl-CoA dehydrogenase |
788 |
0.64 |
chr4_2287102_2287253 | 1.45 |
ZFYVE28 |
zinc finger, FYVE domain containing 28 |
2265 |
0.21 |
chr21_38080447_38080598 | 1.45 |
SIM2 |
single-minded family bHLH transcription factor 2 |
959 |
0.59 |
chr5_98110261_98110463 | 1.45 |
RGMB |
repulsive guidance molecule family member b |
1023 |
0.44 |
chr10_45914496_45914647 | 1.45 |
RP11-67C2.2 |
|
33998 |
0.17 |
chr6_27791891_27792120 | 1.44 |
HIST1H4J |
histone cluster 1, H4j |
121 |
0.89 |
chr6_87865528_87865679 | 1.43 |
ZNF292 |
zinc finger protein 292 |
264 |
0.76 |
chr9_131450953_131451104 | 1.43 |
SET |
SET nuclear oncogene |
477 |
0.67 |
chr19_54664009_54664198 | 1.43 |
LENG1 |
leukocyte receptor cluster (LRC) member 1 |
483 |
0.57 |
chr19_54057887_54058079 | 1.43 |
ZNF331 |
zinc finger protein 331 |
98 |
0.94 |
chr20_1206742_1206987 | 1.42 |
RAD21L1 |
RAD21-like 1 (S. pombe) |
85 |
0.96 |
chr13_53419617_53419799 | 1.42 |
PCDH8 |
protocadherin 8 |
2932 |
0.32 |
chr9_38622054_38622296 | 1.41 |
FAM201A |
family with sequence similarity 201, member A |
1090 |
0.44 |
chr1_153748137_153748288 | 1.40 |
SLC27A3 |
solute carrier family 27 (fatty acid transporter), member 3 |
444 |
0.68 |
chr7_27211584_27211735 | 1.40 |
HOXA10 |
homeobox A10 |
2266 |
0.09 |
chr6_114179587_114179793 | 1.39 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
1149 |
0.5 |
chr9_130965791_130965942 | 1.38 |
DNM1 |
dynamin 1 |
141 |
0.86 |
chr15_63481295_63481446 | 1.38 |
RAB8B |
RAB8B, member RAS oncogene family |
298 |
0.91 |
chr5_133801886_133802081 | 1.38 |
ENSG00000207222 |
. |
33992 |
0.12 |
chr7_87849531_87849682 | 1.37 |
SRI |
sorcin |
212 |
0.87 |
chr1_111149528_111149773 | 1.37 |
KCNA2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
401 |
0.86 |
chr13_21634066_21634513 | 1.37 |
LATS2 |
large tumor suppressor kinase 2 |
140 |
0.95 |
chr1_117350633_117350815 | 1.37 |
CD2 |
CD2 molecule |
53635 |
0.12 |
chr13_46422018_46422199 | 1.36 |
SIAH3 |
siah E3 ubiquitin protein ligase family member 3 |
3763 |
0.32 |
chr8_144658970_144659208 | 1.36 |
NAPRT1 |
nicotinate phosphoribosyltransferase domain containing 1 |
1419 |
0.16 |
chr7_21583341_21583558 | 1.35 |
DNAH11 |
dynein, axonemal, heavy chain 11 |
616 |
0.81 |
chr1_19615082_19615236 | 1.35 |
AKR7A3 |
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
585 |
0.6 |
chr6_3157600_3157751 | 1.35 |
TUBB2A |
tubulin, beta 2A class IIa |
85 |
0.96 |
chr16_691563_691714 | 1.35 |
FAM195A |
family with sequence similarity 195, member A |
175 |
0.83 |
chr1_101004881_101005040 | 1.35 |
GPR88 |
G protein-coupled receptor 88 |
1267 |
0.55 |
chr1_207818463_207818614 | 1.35 |
CR1L |
complement component (3b/4b) receptor 1-like |
19 |
0.98 |
chr16_57563341_57563492 | 1.34 |
CCDC102A |
coiled-coil domain containing 102A |
7095 |
0.15 |
chr14_72399117_72399268 | 1.34 |
RGS6 |
regulator of G-protein signaling 6 |
36 |
0.99 |
chr2_172960097_172960248 | 1.33 |
DLX2 |
distal-less homeobox 2 |
7456 |
0.21 |
chr7_70160257_70160483 | 1.33 |
AUTS2 |
autism susceptibility candidate 2 |
33755 |
0.25 |
chr11_44599790_44600020 | 1.33 |
CD82 |
CD82 molecule |
5277 |
0.23 |
chr9_114361618_114361849 | 1.32 |
PTGR1 |
prostaglandin reductase 1 |
46 |
0.97 |
chr13_101262318_101262661 | 1.31 |
GGACT |
gamma-glutamylamine cyclotransferase |
20707 |
0.19 |
chr18_24127643_24127794 | 1.31 |
KCTD1 |
potassium channel tetramerization domain containing 1 |
636 |
0.79 |
chr13_46741812_46742603 | 1.31 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
447 |
0.76 |
chr1_19717565_19717716 | 1.30 |
CAPZB |
capping protein (actin filament) muscle Z-line, beta |
5349 |
0.18 |
chr17_3817365_3817516 | 1.30 |
P2RX1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
2354 |
0.25 |
chr16_4743238_4743389 | 1.30 |
NUDT16L1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 |
382 |
0.78 |
chr20_10415063_10415257 | 1.30 |
MKKS |
McKusick-Kaufman syndrome |
290 |
0.8 |
chr10_50605770_50606052 | 1.30 |
DRGX |
dorsal root ganglia homeobox |
2414 |
0.3 |
chrX_69665028_69665234 | 1.30 |
DLG3 |
discs, large homolog 3 (Drosophila) |
312 |
0.86 |
chr16_27335428_27335591 | 1.29 |
IL4R |
interleukin 4 receptor |
10196 |
0.2 |
chr9_137266638_137266789 | 1.29 |
ENSG00000263897 |
. |
4544 |
0.28 |
chr10_135090602_135090753 | 1.29 |
ADAM8 |
ADAM metallopeptidase domain 8 |
305 |
0.81 |
chr1_148854279_148854641 | 1.29 |
ENSG00000222854 |
. |
58922 |
0.13 |
chr16_88985065_88985222 | 1.29 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
16220 |
0.11 |
chr14_31343429_31343580 | 1.29 |
COCH |
cochlin |
245 |
0.93 |
chr13_47166086_47166307 | 1.29 |
LRCH1 |
leucine-rich repeats and calponin homology (CH) domain containing 1 |
38801 |
0.2 |
chr5_73937813_73938003 | 1.28 |
ENC1 |
ectodermal-neural cortex 1 (with BTB domain) |
659 |
0.69 |
chr4_99578599_99578919 | 1.28 |
TSPAN5 |
tetraspanin 5 |
27 |
0.97 |
chr17_48278292_48278683 | 1.28 |
COL1A1 |
collagen, type I, alpha 1 |
506 |
0.68 |
chr1_6661858_6662009 | 1.28 |
KLHL21 |
kelch-like family member 21 |
996 |
0.41 |
chr5_177026713_177026864 | 1.28 |
B4GALT7 |
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 |
313 |
0.84 |
chr1_100816836_100817004 | 1.28 |
CDC14A |
cell division cycle 14A |
370 |
0.87 |
chr1_91316739_91316970 | 1.27 |
BARHL2 |
BarH-like homeobox 2 |
134060 |
0.05 |
chr18_47721158_47721348 | 1.27 |
MYO5B |
myosin VB |
210 |
0.94 |
chr15_43213433_43213679 | 1.27 |
TTBK2 |
tau tubulin kinase 2 |
549 |
0.84 |
chr13_50704774_50704931 | 1.27 |
DLEU1 |
deleted in lymphocytic leukemia 1 (non-protein coding) |
48545 |
0.13 |
chr2_31360877_31361061 | 1.27 |
GALNT14 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
7 |
0.98 |
chr12_93985070_93985442 | 1.27 |
SOCS2 |
suppressor of cytokine signaling 2 |
16422 |
0.18 |
chr8_143456854_143457005 | 1.27 |
TSNARE1 |
t-SNARE domain containing 1 |
20805 |
0.19 |
chr15_44719994_44720235 | 1.27 |
CTDSPL2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 |
102 |
0.91 |
chr12_124780827_124780978 | 1.27 |
FAM101A |
family with sequence similarity 101, member A |
833 |
0.7 |
chr17_78450343_78450494 | 1.26 |
NPTX1 |
neuronal pentraxin I |
14 |
0.98 |
chr2_38830469_38830643 | 1.26 |
HNRNPLL |
heterogeneous nuclear ribonucleoprotein L-like |
378 |
0.83 |
chr17_26711668_26711819 | 1.26 |
SARM1 |
sterile alpha and TIR motif containing 1 |
376 |
0.67 |
chr4_37454974_37455367 | 1.26 |
C4orf19 |
chromosome 4 open reading frame 19 |
393 |
0.92 |
chr17_46894164_46894376 | 1.26 |
TTLL6 |
tubulin tyrosine ligase-like family, member 6 |
306 |
0.84 |
chr9_89561479_89561630 | 1.26 |
GAS1 |
growth arrest-specific 1 |
550 |
0.87 |
chr10_74385345_74385496 | 1.26 |
MICU1 |
mitochondrial calcium uptake 1 |
416 |
0.82 |
chr4_55098029_55098180 | 1.26 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
1615 |
0.5 |
chr9_36986446_36986597 | 1.25 |
PAX5 |
paired box 5 |
16151 |
0.19 |
chr12_105071136_105071342 | 1.25 |
ENSG00000264295 |
. |
85828 |
0.09 |
chr14_52959290_52959441 | 1.25 |
TXNDC16 |
thioredoxin domain containing 16 |
59858 |
0.12 |
chr1_40562951_40563102 | 1.25 |
PPT1 |
palmitoyl-protein thioesterase 1 |
102 |
0.97 |
chr11_67276247_67276473 | 1.25 |
CDK2AP2 |
cyclin-dependent kinase 2 associated protein 2 |
258 |
0.81 |
chr19_14317810_14317961 | 1.25 |
LPHN1 |
latrophilin 1 |
886 |
0.51 |
chr17_61862930_61863081 | 1.25 |
DDX42 |
DEAD (Asp-Glu-Ala-Asp) box helicase 42 |
1405 |
0.29 |
chr7_72300505_72300656 | 1.25 |
SBDSP1 |
Shwachman-Bodian-Diamond syndrome pseudogene 1 |
345 |
0.79 |
chr5_131630226_131630559 | 1.25 |
SLC22A4 |
solute carrier family 22 (organic cation/zwitterion transporter), member 4 |
256 |
0.73 |
chr4_154143713_154143951 | 1.25 |
TRIM2 |
tripartite motif containing 2 |
18214 |
0.19 |
chr9_139740881_139741032 | 1.25 |
C9orf172 |
chromosome 9 open reading frame 172 |
2089 |
0.11 |
chr12_89436439_89436590 | 1.25 |
ENSG00000238302 |
. |
239548 |
0.02 |
chr14_59931386_59931582 | 1.24 |
GPR135 |
G protein-coupled receptor 135 |
576 |
0.75 |
chr2_148394331_148394482 | 1.24 |
ENSG00000253083 |
. |
76717 |
0.11 |
chr2_27487537_27487721 | 1.24 |
SLC30A3 |
solute carrier family 30 (zinc transporter), member 3 |
625 |
0.53 |
chr17_73840335_73840507 | 1.24 |
UNC13D |
unc-13 homolog D (C. elegans) |
6 |
0.95 |
chr12_113573193_113573409 | 1.24 |
RASAL1 |
RAS protein activator like 1 (GAP1 like) |
8 |
0.96 |
chr12_133030757_133030908 | 1.24 |
MUC8 |
mucin 8 |
19894 |
0.19 |
chr11_67165283_67165521 | 1.24 |
ENSG00000253024 |
. |
2620 |
0.1 |
chr9_21559540_21559691 | 1.23 |
MIR31HG |
MIR31 host gene (non-protein coding) |
53 |
0.98 |
chr16_25025749_25026156 | 1.23 |
ARHGAP17 |
Rho GTPase activating protein 17 |
700 |
0.78 |
chr15_75940809_75940992 | 1.23 |
IMP3 |
IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
147 |
0.84 |
chr5_141016782_141016933 | 1.23 |
RELL2 |
RELT-like 2 |
152 |
0.76 |
chr2_220363120_220363283 | 1.22 |
RP11-316O14.1 |
|
233 |
0.61 |
chr2_233180899_233181095 | 1.22 |
DIS3L2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2 |
17656 |
0.17 |
chr22_38610141_38610397 | 1.22 |
MAFF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
727 |
0.54 |
chr2_158733347_158733721 | 1.22 |
UPP2 |
uridine phosphorylase 2 |
320 |
0.82 |
chr5_172198736_172199095 | 1.21 |
DUSP1 |
dual specificity phosphatase 1 |
717 |
0.59 |
chr14_90422513_90422664 | 1.21 |
TDP1 |
tyrosyl-DNA phosphodiesterase 1 |
207 |
0.93 |
chr17_75243284_75243621 | 1.21 |
SEPT9 |
septin 9 |
33199 |
0.16 |
chr2_105473259_105473410 | 1.21 |
POU3F3 |
POU class 3 homeobox 3 |
1365 |
0.32 |
chr14_77499305_77499456 | 1.21 |
IRF2BPL |
interferon regulatory factor 2 binding protein-like |
4346 |
0.23 |
chr1_155293264_155293415 | 1.21 |
RUSC1 |
RUN and SH3 domain containing 1 |
389 |
0.54 |
chr8_38325731_38325987 | 1.20 |
FGFR1 |
fibroblast growth factor receptor 1 |
275 |
0.9 |
chr1_185703531_185703682 | 1.20 |
HMCN1 |
hemicentin 1 |
77 |
0.98 |
chr19_4064720_4064871 | 1.20 |
ZBTB7A |
zinc finger and BTB domain containing 7A |
935 |
0.4 |
chr1_39024766_39024977 | 1.20 |
ENSG00000200796 |
. |
162540 |
0.04 |
chr3_112931227_112931578 | 1.20 |
BOC |
BOC cell adhesion associated, oncogene regulated |
7 |
0.98 |
chr18_45936416_45936655 | 1.20 |
ZBTB7C |
zinc finger and BTB domain containing 7C |
588 |
0.78 |
chr11_66024851_66025009 | 1.20 |
KLC2 |
kinesin light chain 2 |
161 |
0.86 |
chr17_38267680_38267831 | 1.20 |
NR1D1 |
nuclear receptor subfamily 1, group D, member 1 |
10777 |
0.11 |
chr2_1746792_1747088 | 1.20 |
PXDN |
peroxidasin homolog (Drosophila) |
1274 |
0.58 |
chr5_43192447_43192612 | 1.20 |
NIM1K |
NIM1 serine/threonine protein kinase |
202 |
0.95 |
chr6_106925572_106925819 | 1.20 |
ENSG00000200314 |
. |
22992 |
0.15 |
chr5_140019395_140019546 | 1.19 |
TMCO6 |
transmembrane and coiled-coil domains 6 |
381 |
0.67 |
chr3_177316753_177317103 | 1.19 |
ENSG00000200288 |
. |
25269 |
0.26 |
chr4_52710635_52710892 | 1.19 |
DCUN1D4 |
DCN1, defective in cullin neddylation 1, domain containing 4 |
1018 |
0.7 |
chr20_25370650_25370901 | 1.19 |
ABHD12 |
abhydrolase domain containing 12 |
5 |
0.98 |
chr8_24813964_24814209 | 1.19 |
CTD-2168K21.2 |
|
49 |
0.98 |
chr15_82338853_82339083 | 1.19 |
MEX3B |
mex-3 RNA binding family member B |
486 |
0.79 |
chr5_154237315_154237466 | 1.19 |
CNOT8 |
CCR4-NOT transcription complex, subunit 8 |
419 |
0.76 |
chr19_1840303_1840561 | 1.19 |
REXO1 |
REX1, RNA exonuclease 1 homolog (S. cerevisiae) |
8020 |
0.08 |
chr17_81021007_81021158 | 1.19 |
B3GNTL1 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 |
11396 |
0.21 |
chr5_115788448_115788731 | 1.19 |
CTB-118N6.3 |
|
3163 |
0.29 |
chr12_129307923_129308074 | 1.18 |
SLC15A4 |
solute carrier family 15 (oligopeptide transporter), member 4 |
69 |
0.98 |
chr19_5903627_5903778 | 1.18 |
AC024592.12 |
Uncharacterized protein |
12 |
0.38 |
chr15_93180047_93180198 | 1.18 |
FAM174B |
family with sequence similarity 174, member B |
2352 |
0.36 |
chr14_65372991_65373142 | 1.18 |
ENSG00000252497 |
. |
3432 |
0.15 |
chr2_25388913_25389282 | 1.18 |
POMC |
proopiomelanocortin |
2343 |
0.3 |
chr1_11538959_11539184 | 1.17 |
PTCHD2 |
patched domain containing 2 |
224 |
0.95 |
chr14_61115485_61115674 | 1.17 |
SIX1 |
SIX homeobox 1 |
601 |
0.77 |
chr1_235133061_235133212 | 1.17 |
ENSG00000239690 |
. |
93203 |
0.08 |
chr4_146402600_146402751 | 1.17 |
SMAD1 |
SMAD family member 1 |
175 |
0.96 |
chr5_153824571_153824722 | 1.17 |
SAP30L-AS1 |
SAP30L antisense RNA 1 (head to head) |
727 |
0.45 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.9 | 3.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.8 | 1.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.8 | 0.8 | GO:0048675 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.8 | 2.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.7 | 1.5 | GO:0051138 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.7 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 2.1 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.7 | 2.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.7 | 3.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.7 | 1.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.6 | 1.9 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.6 | 1.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 1.2 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.6 | 1.8 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.6 | 2.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 1.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 1.7 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.5 | 0.5 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.5 | 1.6 | GO:0001705 | ectoderm formation(GO:0001705) |
0.5 | 2.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.5 | 2.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.5 | 1.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.5 | 1.0 | GO:0072182 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.5 | 3.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 1.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 2.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.5 | 1.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 1.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.5 | 1.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.5 | 1.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.5 | 1.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 0.9 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.5 | 1.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.5 | 1.8 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 0.9 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.4 | 1.3 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.4 | 2.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.4 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.4 | 3.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.4 | 0.4 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.4 | 1.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 1.7 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 3.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.4 | 1.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 1.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 2.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 1.3 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.4 | 3.3 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.4 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.4 | 3.2 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.4 | 1.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 5.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.4 | 3.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.4 | 1.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.5 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.4 | 1.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 0.7 | GO:0001570 | vasculogenesis(GO:0001570) |
0.4 | 1.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 0.4 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.4 | 2.2 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 1.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 1.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 1.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 1.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 0.3 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 2.4 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 3.4 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 0.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 1.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 1.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.3 | 1.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 1.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.3 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 1.0 | GO:0045007 | depurination(GO:0045007) |
0.3 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 1.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 1.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 1.0 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.3 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.3 | 2.5 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.3 | 0.3 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
0.3 | 5.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 0.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 2.8 | GO:0030238 | male sex determination(GO:0030238) |
0.3 | 0.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.3 | 1.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.3 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.3 | 1.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 1.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 1.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.9 | GO:0046931 | pore complex assembly(GO:0046931) |
0.3 | 1.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.3 | 1.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.6 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 1.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 0.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 1.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 1.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 3.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.3 | 0.9 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.3 | 0.9 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.3 | 1.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 0.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.3 | 0.9 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.3 | 2.5 | GO:0030903 | notochord development(GO:0030903) |
0.3 | 0.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 2.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 0.8 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.3 | 0.6 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 0.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 1.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 1.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.3 | 0.3 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.3 | 0.3 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.3 | 1.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.3 | 1.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.3 | GO:0017145 | stem cell division(GO:0017145) |
0.3 | 1.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 0.8 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 0.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 1.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.3 | 1.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.3 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.3 | 1.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 1.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.3 | 2.9 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.3 | 2.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 0.8 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.3 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 1.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 1.5 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.3 | 1.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.8 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 1.2 | GO:0006560 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.2 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 1.5 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.2 | 1.5 | GO:0033235 | regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
0.2 | 0.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.2 | 0.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.2 | GO:0021782 | glial cell development(GO:0021782) |
0.2 | 0.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.5 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.9 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.2 | 0.5 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 0.9 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.5 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.2 | 0.7 | GO:1901978 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 1.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.9 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.2 | GO:0021517 | ventral spinal cord development(GO:0021517) spinal cord motor neuron differentiation(GO:0021522) |
0.2 | 0.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 1.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 1.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.4 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.9 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.7 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.7 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 0.9 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.2 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 1.5 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 3.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 2.3 | GO:0001504 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.2 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 1.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 0.4 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.2 | 0.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 1.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.6 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 2.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.4 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.6 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.8 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.2 | 1.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 0.2 | GO:0001889 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
0.2 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 0.2 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.2 | 1.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.2 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.2 | 0.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.2 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.2 | 1.0 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.2 | 0.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.6 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 1.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.2 | GO:0060021 | palate development(GO:0060021) |
0.2 | 0.4 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 0.4 | GO:0031503 | protein complex localization(GO:0031503) |
0.2 | 0.2 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.2 | 0.4 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.2 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.2 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.6 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 1.5 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 0.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.6 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.2 | 0.6 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.2 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 1.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.7 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 0.2 | GO:0008064 | regulation of actin polymerization or depolymerization(GO:0008064) |
0.2 | 0.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 0.9 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 1.4 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.2 | 0.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 1.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.2 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.2 | 1.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.5 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.2 | 0.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 1.2 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.2 | 1.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 1.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.2 | 0.5 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.2 | 0.3 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 1.5 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 1.5 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.5 | GO:0060039 | pericardium development(GO:0060039) |
0.2 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.8 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.8 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 0.8 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.5 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 0.7 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.2 | 1.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 1.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 0.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 1.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.5 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.2 | 0.6 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 1.0 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.2 | 0.2 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.2 | 0.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.3 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.2 | 0.5 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.2 | 1.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.8 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.2 | 2.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.2 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.2 | 0.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 1.6 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.8 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.2 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.3 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.2 | 0.6 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.2 | 4.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 0.3 | GO:0010873 | obsolete regulation of natriuresis(GO:0003078) positive regulation of cholesterol esterification(GO:0010873) |
0.2 | 0.2 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.2 | 1.4 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.2 | 0.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.2 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.2 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 1.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 1.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.3 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.8 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.1 | 0.3 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 0.4 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 1.8 | GO:0051153 | regulation of striated muscle cell differentiation(GO:0051153) |
0.1 | 0.3 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.3 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.7 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 1.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.3 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 2.0 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.1 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.6 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.1 | GO:2000846 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.1 | 0.6 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 1.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.0 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 0.3 | GO:0051882 | mitochondrial depolarization(GO:0051882) regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.8 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.4 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 1.5 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.1 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.8 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.3 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.1 | GO:0032231 | regulation of actin filament bundle assembly(GO:0032231) |
0.1 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 1.4 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.1 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.6 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 1.2 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.4 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.9 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.4 | GO:0046083 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.4 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.1 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
0.1 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 1.2 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.1 | 0.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 2.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 1.2 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 1.0 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 2.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 2.1 | GO:0061641 | DNA replication-independent nucleosome assembly(GO:0006336) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.4 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 3.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.4 | GO:0006991 | response to sterol depletion(GO:0006991) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.1 | 0.4 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.5 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.3 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:0090312 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.5 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 2.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.5 | GO:0060996 | dendritic spine development(GO:0060996) |
0.1 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.4 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
0.1 | 0.7 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 1.0 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.1 | 1.0 | GO:1902593 | protein import into nucleus(GO:0006606) protein targeting to nucleus(GO:0044744) single-organism nuclear import(GO:1902593) |
0.1 | 0.4 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.4 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.1 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 5.1 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.1 | 0.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.8 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 0.1 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.1 | 2.9 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.1 | 1.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 1.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.8 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.7 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.2 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.1 | 0.2 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.6 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 2.0 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 2.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0032892 | positive regulation of organic acid transport(GO:0032892) |
0.1 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
0.1 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.3 | GO:0007346 | regulation of mitotic cell cycle(GO:0007346) |
0.1 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.4 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.7 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.6 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.3 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.4 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.7 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.1 | 0.3 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.3 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.4 | GO:0060323 | head morphogenesis(GO:0060323) |
0.1 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 1.8 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.6 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 3.8 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.1 | 0.2 | GO:0042312 | regulation of vasodilation(GO:0042312) |
0.1 | 0.4 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 1.8 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 0.7 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 2.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.8 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 1.6 | GO:0030032 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
0.1 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.8 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.1 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 0.3 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.1 | GO:1904748 | development of secondary sexual characteristics(GO:0045136) regulation of apoptotic process involved in morphogenesis(GO:1902337) regulation of apoptotic process involved in development(GO:1904748) |
0.1 | 0.6 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.1 | 0.1 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.4 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.3 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.3 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 1.9 | GO:0072523 | purine-containing compound catabolic process(GO:0072523) |
0.1 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.4 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 2.0 | GO:0006885 | regulation of pH(GO:0006885) |
0.1 | 0.3 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.1 | 1.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 1.4 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.1 | 0.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.2 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.5 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 0.4 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 1.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.7 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.1 | 0.7 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.1 | 0.1 | GO:0072201 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of mesenchymal cell proliferation(GO:0072201) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.4 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.1 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 1.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.2 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.4 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.8 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.6 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.9 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 2.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.2 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.1 | 0.4 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 0.1 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.1 | 0.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 1.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 1.4 | GO:1901343 | negative regulation of angiogenesis(GO:0016525) negative regulation of vasculature development(GO:1901343) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.5 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.1 | 0.9 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 2.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.4 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.1 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 8.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.2 | GO:0046635 | positive regulation of alpha-beta T cell activation(GO:0046635) |
0.1 | 0.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.4 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.1 | 1.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 1.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.4 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.3 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.1 | 3.6 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.3 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.1 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.1 | 0.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 1.4 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.4 | GO:0051875 | pigment granule localization(GO:0051875) |
0.1 | 0.8 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.1 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.3 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.1 | 2.4 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.2 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.3 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.1 | 0.3 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.3 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 1.0 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 8.7 | GO:0016311 | dephosphorylation(GO:0016311) |
0.1 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.1 | 2.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.2 | GO:0071675 | regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 3.8 | GO:0071772 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 1.7 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.1 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 1.9 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.7 | GO:0001508 | action potential(GO:0001508) |
0.1 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 1.4 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.1 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.1 | 0.6 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 2.4 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.1 | 0.5 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.8 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.2 | GO:0045916 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.3 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.2 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.5 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.1 | 0.2 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.4 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.2 | GO:0044089 | positive regulation of cellular component biogenesis(GO:0044089) |
0.1 | 0.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.1 | GO:0002857 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 2.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 1.1 | GO:0051302 | regulation of cell division(GO:0051302) |
0.1 | 0.4 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 4.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.4 | GO:0042551 | neuron maturation(GO:0042551) |
0.1 | 1.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 1.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.1 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 2.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
0.1 | 0.1 | GO:0050663 | cytokine secretion(GO:0050663) |
0.1 | 0.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 1.2 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.4 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 1.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.1 | 0.1 | GO:0048285 | organelle fission(GO:0048285) |
0.1 | 0.3 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.1 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.5 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.2 | GO:0045862 | positive regulation of proteolysis(GO:0045862) |
0.1 | 0.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.7 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.3 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.1 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.6 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.1 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.6 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.1 | 1.8 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 2.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.1 | GO:0010518 | regulation of phospholipase activity(GO:0010517) positive regulation of phospholipase activity(GO:0010518) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 1.5 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.2 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 4.2 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.3 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 1.2 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.1 | 2.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.6 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.1 | 1.2 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.1 | 0.6 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.1 | 2.3 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.1 | GO:0070646 | protein deubiquitination(GO:0016579) protein modification by small protein removal(GO:0070646) |
0.1 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.1 | GO:0021510 | spinal cord development(GO:0021510) |
0.1 | 0.6 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 6.8 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.1 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 2.2 | GO:0009185 | ribonucleoside diphosphate metabolic process(GO:0009185) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.1 | GO:0060479 | lung cell differentiation(GO:0060479) |
0.1 | 0.6 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.2 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 0.4 | GO:0043473 | pigmentation(GO:0043473) |
0.1 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.7 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.1 | 0.1 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.2 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.4 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 3.5 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 4.5 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 2.0 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.9 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.4 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 1.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) negative regulation of glycoprotein metabolic process(GO:1903019) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.9 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.7 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.3 | GO:0051147 | regulation of muscle cell differentiation(GO:0051147) |
0.1 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.2 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.7 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.1 | GO:0046112 | purine nucleobase biosynthetic process(GO:0009113) nucleobase biosynthetic process(GO:0046112) |
0.1 | 0.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.3 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.2 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.1 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.7 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 2.2 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.0 | 0.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.9 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.0 | 0.1 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.2 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.2 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.0 | 0.2 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.7 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.6 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.0 | 0.0 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 1.0 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 1.0 | GO:0097193 | intrinsic apoptotic signaling pathway(GO:0097193) |
0.0 | 1.2 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.2 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 7.1 | GO:0030163 | protein catabolic process(GO:0030163) |
0.0 | 0.0 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.6 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.0 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.3 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 1.0 | GO:0007623 | circadian rhythm(GO:0007623) |
0.0 | 2.1 | GO:0010565 | regulation of cellular ketone metabolic process(GO:0010565) |
0.0 | 0.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.4 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 4.6 | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules(GO:0098742) |
0.0 | 0.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.0 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.2 | GO:1903409 | reactive oxygen species biosynthetic process(GO:1903409) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.4 | GO:0016571 | histone methylation(GO:0016571) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.5 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.1 | GO:0051783 | regulation of nuclear division(GO:0051783) |
0.0 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.4 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.1 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.9 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.1 | GO:0051324 | prophase(GO:0051324) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.0 | GO:0045165 | cell fate commitment(GO:0045165) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 2.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 1.4 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 1.9 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.2 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.1 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.0 | 0.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 1.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.5 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.0 | 0.0 | GO:0010564 | regulation of cell cycle process(GO:0010564) |
0.0 | 0.1 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.9 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:0021915 | neural tube development(GO:0021915) |
0.0 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 1.0 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.0 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.1 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.3 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.2 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 1.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.0 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.0 | 0.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.6 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.0 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) axial mesoderm development(GO:0048318) axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.0 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.0 | 5.6 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 6.4 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.0 | 0.1 | GO:0042267 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.2 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
0.0 | 0.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.0 | GO:0009451 | RNA modification(GO:0009451) |
0.0 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 2.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.2 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 0.0 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.2 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.0 | GO:0046890 | regulation of lipid biosynthetic process(GO:0046890) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.3 | GO:0097696 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
0.0 | 0.6 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.2 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.1 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 0.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.0 | GO:0009220 | pyrimidine ribonucleotide biosynthetic process(GO:0009220) |
0.0 | 0.8 | GO:0007126 | meiotic nuclear division(GO:0007126) |
0.0 | 0.0 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.0 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.0 | 0.6 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.7 | GO:0051403 | stress-activated MAPK cascade(GO:0051403) |
0.0 | 0.3 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.0 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.0 | 0.1 | GO:0034311 | diol metabolic process(GO:0034311) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.2 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.0 | 0.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.8 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.7 | GO:0050900 | leukocyte migration(GO:0050900) |
0.0 | 0.0 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 2.7 | GO:0006325 | chromatin organization(GO:0006325) |
0.0 | 0.9 | GO:0006897 | endocytosis(GO:0006897) |
0.0 | 0.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.0 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.0 | 0.0 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.0 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.1 | GO:0071826 | ribonucleoprotein complex subunit organization(GO:0071826) |
0.0 | 0.0 | GO:0043471 | regulation of glycogen catabolic process(GO:0005981) regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.0 | 0.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.0 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.9 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.0 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.0 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.0 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.0 | 0.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.2 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 1.2 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 3.8 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0009855 | specification of symmetry(GO:0009799) determination of bilateral symmetry(GO:0009855) |
0.0 | 0.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.0 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.8 | GO:0006865 | amino acid transport(GO:0006865) |
0.0 | 0.0 | GO:0061387 | regulation of extent of cell growth(GO:0061387) |
0.0 | 0.0 | GO:0021675 | nerve development(GO:0021675) |
0.0 | 1.1 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.0 | 0.0 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.2 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.2 | GO:0044247 | polysaccharide catabolic process(GO:0000272) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0032674 | interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
0.0 | 0.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.4 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.0 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.0 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 12.9 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.0 | 0.1 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.6 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.0 | GO:0044058 | regulation of digestive system process(GO:0044058) |
0.0 | 0.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.0 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.0 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 3.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 1.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 1.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 1.5 | GO:0032059 | bleb(GO:0032059) |
0.4 | 1.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 1.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 3.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 0.3 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 1.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 0.3 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.3 | 2.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 1.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 1.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 6.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 1.2 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 1.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 2.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.3 | 1.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.3 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 2.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.0 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 1.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 1.4 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.2 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 3.2 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 0.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 1.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 2.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.8 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.2 | 1.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 1.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.2 | GO:0031265 | death-inducing signaling complex(GO:0031264) CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 2.3 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.3 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.2 | 5.6 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 2.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.9 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 2.1 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 1.0 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 1.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 1.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.0 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 1.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.4 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.2 | GO:0012505 | endomembrane system(GO:0012505) |
0.2 | 0.6 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 1.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.9 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 0.6 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 1.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 3.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 1.7 | GO:0005792 | obsolete microsome(GO:0005792) |
0.2 | 0.5 | GO:0098590 | plasma membrane region(GO:0098590) |
0.2 | 0.9 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.2 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.9 | GO:0032154 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.1 | 3.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.7 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 2.5 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.0 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 1.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.8 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 4.8 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 1.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.9 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.5 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 1.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.8 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 2.5 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 1.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 5.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 2.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 11.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 4.7 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 3.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 4.8 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 5.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 5.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.9 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 6.1 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.4 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.1 | 1.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 2.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 1.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.1 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.1 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 9.1 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 2.3 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 3.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 2.5 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 3.2 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.9 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.1 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 0.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.1 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 0.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 4.4 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 5.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 11.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 5.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.2 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 6.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 3.7 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 13.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 2.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 8.2 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 1.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 3.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 56.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 2.0 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.1 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.5 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 5.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.4 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 1.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 1.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 1.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 20.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 16.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 45.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 3.0 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 4.2 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 1.7 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 3.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.1 | GO:0005768 | endosome(GO:0005768) |
0.1 | 1.8 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 3.7 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 16.4 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.1 | 3.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.1 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 30.0 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 9.0 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.8 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 119.9 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.7 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 17.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.5 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.6 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 3.3 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 1.2 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 6.6 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 20.5 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.4 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 2.6 | GO:0031090 | organelle membrane(GO:0031090) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.6 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.1 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.0 | GO:0031674 | I band(GO:0031674) |
0.0 | 42.9 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 23.9 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.6 | 3.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.6 | 1.9 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.6 | 1.9 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.6 | 1.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 1.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 1.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.6 | 4.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 0.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 1.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 1.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.5 | 1.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 1.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 1.9 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.5 | 2.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 1.4 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.5 | 1.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 1.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.4 | 2.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 0.9 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.4 | 1.7 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.4 | 3.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 2.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 1.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 1.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 1.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.4 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 2.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.4 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 1.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 1.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 1.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 1.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 1.9 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.4 | 1.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.4 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 2.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 1.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 1.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.0 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.3 | 1.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 1.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 1.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.9 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.3 | 4.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 0.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 1.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 2.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 1.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.3 | 1.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 1.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 3.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 1.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 0.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 2.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 1.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 0.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 1.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 0.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 0.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 1.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 1.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.3 | 2.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 0.8 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.3 | 0.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 0.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 0.8 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.3 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 0.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 2.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.3 | 0.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 1.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 3.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.7 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 2.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 1.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 2.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.2 | 0.7 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 0.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 0.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 0.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 3.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.7 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.2 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 1.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 4.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 1.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.5 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 2.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 1.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.2 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 2.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.2 | 0.8 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.2 | 1.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.6 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 2.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 8.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 1.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 0.9 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.2 | 0.3 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 0.9 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 1.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 1.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.2 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 3.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 2.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 1.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 1.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 1.0 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
0.2 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 3.4 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.2 | 1.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.2 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 3.1 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.2 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 2.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 4.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.8 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 1.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 1.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 1.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 2.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.7 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.1 | 1.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 2.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 1.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 3.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 2.0 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.1 | 2.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) bubble DNA binding(GO:0000405) |
0.1 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 5.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 3.9 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 2.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 2.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 1.2 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.1 | 0.4 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 2.3 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 2.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 2.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 2.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 1.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.9 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.1 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.1 | 0.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 1.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.6 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 1.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.5 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 7.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 4.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 2.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.9 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 0.7 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 0.3 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 1.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 4.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 2.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.7 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0009008 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA-methyltransferase activity(GO:0009008) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 1.8 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.6 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 1.1 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 2.5 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 2.7 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 4.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 1.1 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 4.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.3 | GO:0016801 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 9.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 1.0 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.1 | GO:0031543 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline dioxygenase activity(GO:0031543) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 2.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.4 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 1.2 | GO:0005035 | death receptor activity(GO:0005035) |
0.1 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 1.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 1.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.7 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 4.3 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 1.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 3.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.8 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 2.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.4 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.8 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 1.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.7 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.4 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 5.3 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 2.6 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.5 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 13.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 1.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 1.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 1.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 2.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) dioxygenase activity(GO:0051213) |
0.1 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 3.4 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.1 | 1.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 4.8 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 6.3 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.1 | 0.9 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.7 | GO:0017127 | sterol transporter activity(GO:0015248) cholesterol transporter activity(GO:0017127) |
0.1 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.1 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 2.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 2.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.3 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 2.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 1.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 5.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 1.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.7 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.2 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 1.8 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.6 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.4 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 1.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.1 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.8 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.1 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 1.3 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 18.0 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 6.0 | GO:0032561 | GTP binding(GO:0005525) guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.3 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.4 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 9.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 4.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.1 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 56.9 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.8 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.4 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 1.9 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 1.4 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 1.4 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 1.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 1.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 2.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.2 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 5.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 2.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 19.9 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 2.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.3 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.2 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 2.0 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 1.4 | GO:0019901 | protein kinase binding(GO:0019901) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.0 | 6.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 4.2 | GO:0008233 | peptidase activity(GO:0008233) |
0.0 | 0.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.2 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 1.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 4.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 15.6 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 6.4 | GO:0042802 | identical protein binding(GO:0042802) |
0.0 | 0.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.8 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 2.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.4 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0008144 | drug binding(GO:0008144) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.0 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.0 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.6 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 2.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 1.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 2.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 6.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 1.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 0.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 5.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 6.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 2.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 2.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 2.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 1.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 2.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 2.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 0.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 2.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 1.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 4.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 4.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 3.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 2.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 4.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 6.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 3.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 3.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 3.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 2.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 3.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 6.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 2.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 3.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.9 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.0 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 3.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 1.4 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 0.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.3 | 2.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 3.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 3.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 6.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 3.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 2.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 3.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 0.5 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 2.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 12.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 3.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 1.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 4.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 5.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 6.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 3.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 2.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 3.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 2.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 0.6 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 6.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 4.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.7 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 2.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 2.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 4.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 1.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 3.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 2.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 1.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 6.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 2.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.9 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 1.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 4.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 3.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 2.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 2.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 2.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 2.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 12.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.7 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 3.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 2.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 3.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.3 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.5 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 4.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 1.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.5 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 4.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 2.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 5.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 2.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 5.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 13.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.8 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 4.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 3.9 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 1.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.6 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 0.4 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 3.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 4.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 2.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.4 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.9 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.0 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 5.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 2.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 1.5 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 4.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 2.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |